HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 613-624 of 1,979
Drug study icon
TerminatedNCT02909504

Gao NARASD Lithium Study

Official study title

Biomarkers in Mononuclear Blood Cells for Lithium Treatment Response of Bipolar Disorder

This study ended early.

In Cleveland
BipolarityMedication studyAges 18–70
Countries
United States
Sponsor
Keming Gao
Other study type icon
CompletedNCT00460226

Lamictal Bipolar Observational Study

Official study title

A Multi-centre, Observational Study to Evaluate the Incidence of Non-serious Rash in Korean Bipolar I Patients With Lamotrigine Therapy in Real World Setting

This study has finished and is no longer accepting participants.

Location not clearly listed
BipolarityObservational studyAges 18+
Countries
Sponsor
GlaxoSmithKline
Other study type icon
CompletedNCT06005155

Lithium Versus Anticonvulsants and the Risk of Physical Disorders

Official study title

Lithium Versus Anticonvulsants and the Risk of Physical Disorders - Results From a Comprehensive Long-term Nation-wide Population-based Study Emulating a Randomised Trial

This study has finished and is no longer accepting participants.

In Copenhagen
BipolarityObservational studyAges 5–100
Countries
Denmark
Sponsor
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Device study icon
CompletedNCT03160664

Magnetic Seizure Therapy for Bipolar Mania

Official study title

Research on Optimization Program of Magnetic Seizure Therapy for Bipolar Mania Patients

This study has finished and is no longer accepting participants.

In Shanghai
BipolarityDevice studyAges 18–55
Countries
China
Sponsor
Shanghai Mental Health Center
Other study type icon
CompletedNCT00586222

Omega 3 Fatty Acid study

Official study title

Neurometabolic Effects of the Essential Polyunsaturated Fatty Acids in Early-Onset Bipolar Disorder: A Magnetic Resonance Spectroscopy Study

This study has finished and is no longer accepting participants.

In Rochester
BipolarityPlacebo comparisonAges 12–18
Countries
United States
Sponsor
Mayo Clinic
Drug study icon
TerminatedNCT01113541

One-Year study of Oral Ziprasidone in Bipolar people with Metabolic Syndrome

Official study title

A One-year, Phase III, Open-label, Non-comparative Trial of the Effect of Ziprasidone HCl on Metabolic Syndrome Risk Factors in Patients With Bipolar Disorder

This study ended early.

Multiple locations, including Calgary
BipolarityMedication studyAges 18–65
Countries
Canada
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Drug study icon
CompletedNCT00330486

Open Label study of Acamprosate in Bipolar Alcoholics

Official study title

The Use of Acamprosate in Alcohol-Dependent Individuals With Bipolar Disorder

This study has finished and is no longer accepting participants.

In Charleston
BipolarityMedication studyAges 18–65
Countries
United States
Sponsor
Medical University of South Carolina
Drug study icon
CompletedNCT00141505

PK Effects of Bifeprunox & Valproate in Bipolar I

What is this study about?

This study evaluated the safety of Bifeprunox for people with bipolarity.

This study has finished and is no longer accepting participants.

In Atlanta
BipolarityMedication studyAges 18–65
Countries
United States
Sponsor
Solvay Pharmaceuticals

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.